Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
173 | 2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009 | conference and proceedings | 0.104 | 6 | 0 | 70 | 0 | 7 | 69 | 0.00 | 0.00 | |
172 | Advances in Pharmacological Sciences | journal | 0.455 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
171 | Drugs in Context | journal | 36 | 3 | 0 | 310 | 0 | 0 | 0.00 | 103.33 | ||
170 | Frontiers in Drug Design and Discovery | book series | 0.125 Q4 | 9 | 0 | 18 | 0 | 3 | 17 | 0.00 | 0.00 | |
169 | Frontiers in Medicinal Chemistry | book series | 0.231 Q4 | 7 | 17 | 44 | 2779 | 16 | 42 | 0.00 | 163.47 | |
168 | Gene Therapy and Molecular Biology | journal | 0.201 Q4 | 18 | 12 | 30 | 427 | 23 | 30 | 0.00 | 35.58 | |
167 | Human gene therapy methods | journal | 38 | 39 | 0 | 1614 | 0 | 0 | 0.00 | 41.38 | ||
166 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 2 | 1 | 192 | 0 | 1 | 0.00 | 96.00 | |
165 | MedChemComm | journal | 1.042 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
164 | Methods in Pharmacology and Toxicology | book series | 14 | 44 | 0 | 2818 | 0 | 0 | 0.00 | 64.05 | ||
163 | Molecular Therapy - Nucleic Acids | journal | 95 | 62 | 0 | 2345 | 0 | 0 | 0.00 | 37.82 | ||
162 | Recent Patents on Biomarkers | journal | 3 | 12 | 0 | 962 | 0 | 0 | 0.00 | 80.17 | ||
161 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.107 Q4 | 40 | 0 | 6 | 0 | 1 | 6 | 0.00 | 0.00 | |
160 | Sp2 | trade journal | 0.100 Q4 | 2 | 21 | 189 | 24 | 0 | 169 | 0.00 | 1.14 | |
159 | VacciMonitor | journal | 5 | 22 | 0 | 436 | 0 | 0 | 0.00 | 19.82 | ||
158 | Chinese Journal of Cancer Biotherapy | journal | 0.102 Q4 | 5 | 0 | 374 | 0 | 7 | 370 | 0.01 | 0.00 | |
157 | Cellular Therapy and Transplantation | journal | 0.122 Q4 | 8 | 0 | 48 | 0 | 5 | 47 | 0.14 | 0.00 | |
156 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.135 Q4 | 14 | 26 | 59 | 1151 | 9 | 55 | 0.15 | 44.27 | |
155 | European Pharmaceutical Review | trade journal | 0.124 Q4 | 9 | 49 | 102 | 968 | 20 | 94 | 0.22 | 19.76 | |
154 | Topics in Medicinal Chemistry | book series | 0.243 Q4 | 15 | 9 | 33 | 1105 | 13 | 25 | 0.26 | 122.78 | |
153 | 2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010 | conference and proceedings | 0.130 | 5 | 0 | 53 | 0 | 15 | 50 | 0.28 | 0.00 | |
152 | Gene Therapy and Regulation | journal | 0.115 Q4 | 7 | 5 | 18 | 255 | 6 | 16 | 0.33 | 51.00 | |
151 | Open Bioactive Compounds Journal | journal | 0.170 Q4 | 6 | 0 | 6 | 0 | 9 | 6 | 0.33 | 0.00 | |
150 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.202 Q4 | 29 | 13 | 26 | 845 | 8 | 0 | 0.33 | 65.00 | |
149 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.144 Q4 | 16 | 51 | 162 | 1655 | 55 | 162 | 0.36 | 32.45 | |
148 | Turkish Journal of Pharmaceutical Sciences | journal | 0.179 Q4 | 22 | 33 | 74 | 999 | 32 | 74 | 0.37 | 30.27 | |
147 | Pteridines | journal | 0.137 Q4 | 19 | 9 | 34 | 362 | 11 | 33 | 0.41 | 40.22 | |
146 | Nucleus (India) | journal | 0.133 Q4 | 17 | 27 | 4 | 744 | 2 | 4 | 0.50 | 27.56 | |
145 | Pharmacogenomics and Personalized Medicine | journal | 0.150 Q4 | 37 | 11 | 31 | 914 | 13 | 31 | 0.55 | 83.09 | |
144 | Current Cancer Therapy Reviews | journal | 0.226 Q4 | 17 | 39 | 94 | 2649 | 57 | 93 | 0.56 | 67.92 | |
143 | Current Enzyme Inhibition | journal | 0.221 Q4 | 19 | 12 | 68 | 1077 | 49 | 65 | 0.65 | 89.75 | |
142 | Drug Discovery Today: Disease Models | journal | 0.228 Q4 | 33 | 33 | 65 | 1830 | 44 | 56 | 0.67 | 55.45 | |
141 | Drug Discovery Today: Therapeutic Strategies | journal | 0.627 Q3 | 31 | 27 | 57 | 1299 | 59 | 49 | 0.71 | 48.11 | |
140 | Yaoxue Xuebao | journal | 0.250 Q4 | 36 | 266 | 751 | 6333 | 522 | 750 | 0.74 | 23.81 | |
139 | Biomolecules and Therapeutics | journal | 0.239 Q4 | 56 | 80 | 192 | 3528 | 146 | 192 | 0.83 | 44.10 | |
138 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.270 Q4 | 53 | 63 | 297 | 1923 | 249 | 296 | 0.84 | 30.52 | |
137 | Virologica Sinica | journal | 0.293 Q4 | 47 | 48 | 158 | 1264 | 115 | 156 | 0.85 | 26.33 | |
136 | MCB Molecular and Cellular Biomechanics | journal | 0.460 Q3 | 31 | 16 | 52 | 458 | 62 | 52 | 0.89 | 28.63 | |
135 | Letters in Drug Design and Discovery | journal | 0.284 Q4 | 37 | 129 | 344 | 3925 | 319 | 342 | 0.93 | 30.43 | |
134 | Journal of Stem Cells | journal | 0.426 Q4 | 21 | 21 | 57 | 1745 | 71 | 56 | 0.97 | 83.10 | |
133 | Expert Opinion on Medical Diagnostics | journal | 0.274 Q4 | 28 | 53 | 149 | 4043 | 116 | 146 | 1.00 | 76.28 | |
132 | Assay and Drug Development Technologies | journal | 0.834 Q3 | 65 | 89 | 262 | 1729 | 308 | 151 | 1.04 | 19.43 | |
131 | Journal of Asian Natural Products Research | journal | 0.461 Q3 | 51 | 175 | 491 | 2815 | 576 | 490 | 1.10 | 16.09 | |
130 | Personalized Medicine | journal | 0.339 Q4 | 36 | 100 | 240 | 2976 | 245 | 188 | 1.13 | 29.76 | |
129 | Probiotics and Antimicrobial Proteins | journal | 0.343 Q4 | 52 | 32 | 61 | 1450 | 69 | 60 | 1.17 | 45.31 | |
128 | Current Pharmacogenomics and Personalized Medicine | journal | 0.368 Q4 | 20 | 41 | 89 | 2194 | 140 | 72 | 1.24 | 53.51 | |
127 | Journal of Biological Sciences (discontinued) | journal | 0.385 Q4 | 38 | 63 | 313 | 2089 | 360 | 313 | 1.31 | 33.16 | |
126 | International Journal of Peptide Research and Therapeutics | journal | 0.429 Q3 | 45 | 41 | 110 | 1651 | 148 | 109 | 1.37 | 40.27 | |
125 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.412 Q4 | 45 | 23 | 83 | 1226 | 111 | 77 | 1.38 | 53.30 | |
124 | Molecular Medicine Reports | journal | 0.428 Q3 | 86 | 533 | 529 | 15143 | 658 | 529 | 1.41 | 28.41 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®